Detailed information for compound 672533

Basic information

Technical information
  • TDR Targets ID: 672533
  • Name: 2-[2-(4-chlorophenyl)-2-oxoethyl]sulfanyl-5,6 -dimethyl-3-prop-2-enylthieno[3,2-e]pyrimidin -4-one
  • MW: 404.933 | Formula: C19H17ClN2O2S2
  • H donors: 0 H acceptors: 2 LogP: 5.28 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: C=CCn1c(SCC(=O)c2ccc(cc2)Cl)nc2c(c1=O)c(C)c(s2)C
  • InChi: 1S/C19H17ClN2O2S2/c1-4-9-22-18(24)16-11(2)12(3)26-17(16)21-19(22)25-10-15(23)13-5-7-14(20)8-6-13/h4-8H,1,9-10H2,2-3H3
  • InChiKey: XZSVVBMLNSTYQT-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 3-allyl-2-[2-(4-chlorophenyl)-2-oxo-ethyl]sulfanyl-5,6-dimethyl-thieno[3,2-e]pyrimidin-4-one
  • 3-allyl-2-[[2-(4-chlorophenyl)-2-oxoethyl]thio]-5,6-dimethyl-4-thieno[3,2-e]pyrimidinone
  • 3-allyl-2-[[2-(4-chlorophenyl)-2-keto-ethyl]thio]-5,6-dimethyl-thieno[3,2-e]pyrimidin-4-one
  • 2-[2-(4-chlorophenyl)-2-oxo-ethyl]sulfanyl-5,6-dimethyl-3-prop-2-enyl-thieno[3,2-e]pyrimidin-4-one
  • BAS 04913303
  • ZINC00784813
  • ST5050225

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Mycobacterium tuberculosis Conserved hypothetical protein 0.002 0 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.002 0 0.5
Trypanosoma brucei DNA polymerase IV, putative 0.002 0 0.5
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0065 0.3052 1
Schistosoma mansoni tar DNA-binding protein 0.0065 0.3052 0.3052
Echinococcus multilocularis tar DNA binding protein 0.0065 0.3052 0.3052
Trypanosoma brucei DNA polymerase kappa, putative 0.002 0 0.5
Mycobacterium tuberculosis Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) 0.002 0 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.002 0 0.5
Trypanosoma brucei DNA polymerase eta, putative 0.002 0 0.5
Trypanosoma cruzi DNA polymerase kappa, putative 0.002 0 0.5
Trypanosoma brucei DNA polymerase IV, putative 0.002 0 0.5
Brugia malayi RNA binding protein 0.0065 0.3052 1
Trypanosoma brucei DNA polymerase kappa, putative 0.002 0 0.5
Echinococcus granulosus lysine specific demethylase 5A 0.0061 0.2738 0.2738
Schistosoma mansoni jumonji/arid domain-containing protein 0.0061 0.2738 0.2738
Schistosoma mansoni tar DNA-binding protein 0.0065 0.3052 0.3052
Echinococcus granulosus Transcription factor JmjC domain containing protein 0.0061 0.2738 0.2738
Schistosoma mansoni tar DNA-binding protein 0.0065 0.3052 0.3052
Schistosoma mansoni hypothetical protein 0.0169 1 1
Echinococcus granulosus tar DNA binding protein 0.0065 0.3052 0.3052
Trypanosoma brucei DNA polymerase kappa, putative 0.002 0 0.5
Schistosoma mansoni hypothetical protein 0.0169 1 1
Schistosoma mansoni jumonji domain containing protein 0.0061 0.2738 0.2738
Leishmania major DNA polymerase eta, putative 0.002 0 0.5
Trypanosoma brucei DNA polymerase IV, putative 0.002 0 0.5
Echinococcus multilocularis geminin 0.0169 1 1
Entamoeba histolytica deoxycytidyl transferase, putative 0.002 0 0.5
Trichomonas vaginalis DNA polymerase eta, putative 0.002 0 0.5
Trypanosoma cruzi DNA polymerase kappa, putative 0.002 0 0.5
Trypanosoma cruzi DNA polymerase kappa, putative 0.002 0 0.5
Loa Loa (eye worm) jmjC domain-containing protein 0.0061 0.2738 0.8971
Giardia lamblia DINP protein human, muc B family 0.002 0 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.002 0 0.5
Loa Loa (eye worm) RNA binding protein 0.0065 0.3052 1
Schistosoma mansoni jumonji/arid domain-containing protein 0.0061 0.2738 0.2738
Trypanosoma brucei unspecified product 0.002 0 0.5
Brugia malayi TAR-binding protein 0.0065 0.3052 1
Brugia malayi jmjC domain containing protein 0.0061 0.2738 0.8971
Loa Loa (eye worm) TAR-binding protein 0.0065 0.3052 1
Brugia malayi jmjC domain containing protein 0.0061 0.2738 0.8971
Trypanosoma brucei DNA polymerase kappa, putative 0.002 0 0.5
Leishmania major DNA polymerase kappa, putative,DNA polymerase IV, putative 0.002 0 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.002 0 0.5
Mycobacterium ulcerans DNA polymerase IV 0.002 0 0.5
Leishmania major DNA polymerase kappa, putative 0.002 0 0.5
Brugia malayi RNA recognition motif domain containing protein 0.0065 0.3052 1
Trypanosoma brucei DNA polymerase kappa, putative 0.002 0 0.5
Echinococcus multilocularis Transcription factor, JmjC domain containing protein 0.0061 0.2738 0.2738
Trypanosoma cruzi DNA polymerase kappa, putative 0.002 0 0.5
Schistosoma mansoni tar DNA-binding protein 0.0065 0.3052 0.3052
Trichomonas vaginalis DNA polymerase IV / kappa, putative 0.002 0 0.5
Mycobacterium ulcerans DNA polymerase IV 0.002 0 0.5
Echinococcus multilocularis lysine specific demethylase 5A 0.0061 0.2738 0.2738
Schistosoma mansoni tar DNA-binding protein 0.0065 0.3052 0.3052
Trypanosoma cruzi DNA polymerase eta, putative 0.002 0 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.002 0 0.5

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.